Neuropeptide W exerts a potent suppressive effect on blood leptin and insulin concentrations in the rat

International Journal of Molecular Medicine

Volumn 19, Issue 3, 2007, Pages 401-405

  Rucinski, Marcin ^a   Nowak, Krzysztof W ^b   Chmielewska, Joanna ^b   Ziolkowska, Agnieszka ^a   Malendowicz, Ludwik K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Insulin; Islet; Leptin; Neuropeptide b; Neuropeptide B W receptor 1; Neuropeptide B W receptor 2 like; Neuropeptide W; Pancreas; Rat; RT PCR

Indexed keywords

INSULIN; LEPTIN; MESSENGER RNA; NEUROPEPTIDE; NEUROPEPTIDE B; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE W, RAT; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CYTOLOGY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; PANCREAS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; FEMALE; GENE EXPRESSION REGULATION; INJECTIONS, SUBCUTANEOUS; INSULIN; LEPTIN; NEUROPEPTIDES; PANCREAS; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE; RNA, MESSENGER;

EID: 33947539126     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.3.401     Document Type: Article

References (24)

1. O'Dowd BF, Scheideler MA, Nguyen T, Cheng R, Rasmussen JS, Marchese A, Zastawny R, Heng HH, Tsui LC, Shi X, Asa S, Puy L and George SR: The cloning and chromosomal mapping of two novel human opioid-somatostatin-like receptor genes, GPR7 and GPR8, expressed in discrete areas of the brain. Genomics 28: 84-91, 1995.
2. Lee DK, Nguyen T, Porter CA, Cheng R, George SR, Brian F and O'Dowd BF: Two related G protein-coupled receptors: The distribution of GPR7 in rat brain and the absence of GPR8 in rodents. Mol Brain Res 71: 96-103, 1999.
3. Singh G and Davenport AP: Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor system. Br J Pharmacol 148: 1033-1041, 2006.
4. Fujii R, Yoshida H, Fukusumi S, Habata Y, Hosoya M, Kawamata Y, Yano T, Hinuma S, Kitada Ch, Asami T, Mori M, Fujisawa Y and Fujino M: Identification of a neuropeptide modified with bromine as an endogenous ligand for GPR7. J Biol Chem 277: 34010-34016, 2002.
5. Shimomura Y, Harada M, Goto M, Sugo T, Matsumoto Y, Abe M, Watanabe T, Asami T, Kitada Ch, Mori M, Onda H and Fujino M: Identification of neuropeptide W as the endogenous ligand for orphan G-protein-coupled receptors GPR7 and GPR8. J Biol Chem 277: 35826-35832, 2002.
6. Brezillon S, Lannoy V, Franssen JD, Le Poul E, Dupriez V, Lucchetti J, Detheux M and Parmentier M: Identification of natural ligands for the orphan G protein-coupled receptors GPR7 and GPR8. J Biol Chem 278: 776-783, 2003.
7. Ishii M, Fei H and Friedman JM: Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity. Proc Natl Acad Sci USA 100: 10540-10545, 2003.
8. Tanaka H, Yoshida T, Miyamoto N, Motoike T, Kurosu H, Shibata K, Yamanaka A, Williams SC, Richardson JA, Tsujino N, Garry MG, Lerner MR, King DS, O'Dowd BF, Sakurai T and Yanagisawa M: Characterization of a family of endogenous neuropeptide ligands for the G protein-coupled receptors GPR7 and GPR8. Proc Natl Acad Sci USA 100: 6251-6256, 2003.
9. 125I]-NPW radioligand binding and immunocytochemistry. Brain Res 1017: 222-226, 2004.
10. Baker JR, Cardinal K, Bober C, Taylor MM and Samson WK: Neuropeptide W acts in the brain to control prolactin, corticosterone, and growth hormone release. Endocrinology 144: 2816-2821, 2003.
11. Mondal MS, Yamaguchi H, Date Y, Shimbara T, Toshinai Y, Shimomura Y, Mori M and Nakazato M: A role for neuropeptide W in the regulation of feeding behavior. Endocrinology 144: 4729-4733, 2003.
12. Levine AS, Winsky-Sommerer R, Huintron-Resendiz S, Grace MK and de Lecea L: Injection of neuropeptide W into paraventricular nucleus of hypothalamus increases food intake. Am J Physiol Regul Integr Comp Physiol 288: R1727-R1732, 2005.
13. Kelly MA, Beuckmann CT, Williams SC, Sinton CM, Motoike T, Richardson JA, Hammer RE, Garry MG and Yanagisawa M: Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain. Proc Natl Acad Sci USA 102: 9942-9947, 2005.
14. Lacy PE and Kostianovsky M: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39, 1967.
15. Ziolkowska A, Rucinski M, Di Liddo R, Nussdorfer GG and Malendowicz LK: Expression of the beacon gene in endocrine glands of the rat. Peptides 25: 133-137, 2004.
16. Dun SL, Brailoiu GC, Yang J, Chang JK and Dun NJ: Neuropeptide W-immunoreactivity in the hypothalamus and pituitary of the rat. Neurosci Lett 349: 71-74, 2003.
17. Dun SL, Brailoiu GC, Mizuo K, Yang J, Chang JK and Dun NJ: Neuropeptide B immunoreactivity in the central nervous system of the rat. Brain Res 1045: 157-163, 2005.
18. Hochol A, Albertin G, Nussdorfer GG, Spinazzi R, Ziolkowska A, Rucinski M and Malendowicz LK: Effects of neuropeptide B and W on the secretion and growth of rat adrenocortical cells. Int J Mol Med 14: 843-847, 2004.
19. Hochol A, Belloni AS, Rucinski M, Ziolkowska A, Di Liddo R, Nussdorfer GG and Malendowicz LK: Expression of neuropeptide B and W and their receptors in endocrine glands of the rat. Int J Mol Med 18: 1101-1106, 2006.
20. Mazzochi G, Rebuffat P, Ziolkowska A, Rossi GP, Malendowicz LK and Nussdorfer GG: G protein receptors 7 and 8 are expressed in human adrenocortical cells, and their endogenous ligands neuropeptides B and W enhance cortisol secretion by activating adenylate cyclase- and phospholipase C-dependent signaling cascades. J Clin Endocrinol Metab 90: 3466-3471, 2005.
21. Jackson VR, Lin SH, Wang Z, Nothacker HP and Civelli O: A study of the rat neuropeptide B/neuropeptide W system using in situ techniques. J Comp Neurol 497: 367-383, 2006.
22. Samson WK, Baker JR, Samson CK, Samson HW and Taylor MM: Central neuropeptide B administration activates stress hormone secretion and stimulates feeding in male rats. J Neuroendocrinol 16: 842-849, 2004.
23. Niimi M and Murao K: Neuropeptide W as a stress mediator in the hypothalamus. Endocrine 27: 51-54, 2005.
24. Andreis PG, Rucinski M, Neri G, Conconi MT, Petrelli L, Parnigotto PP, Malendowicz LK and Nussdorfer GG: Neuropeptides B and W enhance the growth of human adrenocortical carcinoma-derived NCI-H295 cells by exerting MAPK p42/p44-mediated proliferogenic and antiapoptotic effects. Int J Mol Med 16: 1021-1028, 2005.